top of page

Review of the medicine Symbioflor 2 (Escherichia coli bacteria)

The European Medicines Agency (EMA) has started a review of the medicine Symbioflor 2 (Escherichia coli bacteria), which is authorised in some Member States of the European Union (EU) for treating diseases affecting the stomach and gut including irritable bowel syndrome.

Click on this link for more information.


Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page